The invention provides an agent for the treatment or prevention of viral infection in a subject. The agent is preferably a compound of Formula (I)

##STR00001##

wherein R.sup.1-R.sup.11, X, Y and Q are as defined herein. Also provided are pharmaceutical compositions and combinations comprising such agents. An in vitro method of evaluating the antiviral activity or potential antiviral activity of a compound against a virus is also provided.

The invention provides an agent for the treatment or prevention of viral infection in a subject. The agent is preferably a compound of Formula (I)

##STR00001##

wherein R.sup.1-R.sup.11, X, Y and Q are as defined herein. Also provided are pharmaceutical compositions and combinations comprising such agents. An in vitro method of evaluating the antiviral activity or potential antiviral activity of a compound against a virus is also provided.

The present invention relates to the field of viral disorders, and in particular to the use of natural compounds to inhibit viruses and viral infection. Compositions comprising NGNA are provided for treating or preventing viral infections, such as those causing the common cold.

The present invention relates to the field of viral disorders, and in particular to the use of natural compounds to inhibit viruses and viral infection. Compositions comprising NGNA are provided for treating or preventing viral infections, such as those causing the common cold.

A medicament for use in treating uremia and proteinuria, the medicament being a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

A medicament for use in treating uremia and proteinuria, the medicament being a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

A medicament for use in treating uremia and proteinuria, the medicament being a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.

A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.

A medicament for treating diabetes and complications thereof, the medicament being a glycoprotein, or a mixture of a polysaccharide and a protein, or a polypeptide, or a protein.